Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
BofA/Merrill to hold a summit » 07:51
02/24/20
02/24
07:51
02/24/20
07:51
ELAN

Elanco

$31.16 /

+0.935 (+3.09%)

, IDXX

Idexx Laboratories

$278.55 /

-2.92 (-1.04%)

, KIN

Kindred Biosciences

$10.25 /

+0.85 (+9.04%)

, PETZ

TDH Holdings

$1.46 /

-0.1 (-6.41%)

, ZTS

Zoetis

$142.14 /

-1.39 (-0.97%)

Animal Health Summit to…

Animal Health Summit to be held in New York on February 24.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Trupanion management to meet with RBC Capital » 04:55
02/24/20
02/24
04:55
02/24/20
04:55
TRUP

Trupanion

$32.88 /

-0.88 (-2.61%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Friday
Hot Stocks
Idexx Laboratories director sells 39.1K shares of common stock » 17:29
02/21/20
02/21
17:29
02/21/20
17:29
IDXX

Idexx Laboratories

$278.55 /

-2.92 (-1.04%)

In a regulatory filing,…

In a regulatory filing, Idexx Laboratories disclosed that its director Jonathan Ayers sold 39.1K shares of common stock on February 19th. The total transaction size was about $11.5M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Trupanion management to meet with RBC Capital » 07:12
02/21/20
02/21
07:12
02/21/20
07:12
TRUP

Trupanion

$33.76 /

+0.51 (+1.53%)

Meetings to be held in…

Meetings to be held in Chicago/Milwaukee/Toronto on February 24-28 hosted by RBC Capital.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Recommendations
Trupanion price target raised to $50 from $46 at Lake Street » 08:54
02/14/20
02/14
08:54
02/14/20
08:54
TRUP

Trupanion

$36.51 /

+0.91 (+2.56%)

Lake Street analyst Mark…

Lake Street analyst Mark Argento raised his price target for Trupanion to $50 from $46 and reiterates a Buy rating on the shares citing the company's "strong" quarter. Trupianon beat consensus across the board, driven by strong subscription growth and continued outperformance from the company's "Other Revenue" segment, Argento tells investors in a research note.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Zoetis price target raised to $145 from $130 at SunTrust » 08:43
02/14/20
02/14
08:43
02/14/20
08:43
ZTS

Zoetis

$144.76 /

+1.72 (+1.20%)

SunTrust analyst Gregg…

SunTrust analyst Gregg Gilbert raised his price target on Zoetis to $145 after its "decent" Q4 results and a "solid" outlook for 2020 anticipating strong companion animal growth, a return to growth for livestock, and an overall revenue growth. The analyst still sees Zoetis as a best-in-class animal health company, but maintains his Hold rating on the stock given its "relatively balanced risk/reward".

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Trupanion 'noise' limits near-term upside, says Raymond James » 08:36
02/14/20
02/14
08:36
02/14/20
08:36
TRUP

Trupanion

$36.51 /

+0.91 (+2.56%)

Raymond James analyst…

Raymond James analyst John Ransom downgraded Trupanion to Market Perform from Outperform following the company's "relatively solid" Q4 report, but guidance and commentary that leaves him concerned bears may see another opportunity to poke holes. Ransom says he still thinks the pet insurance market will grow sustainably at a rate near 20% for years to come, but contends that a great end market does not always a great stock make.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Trupanion downgraded to Market Perform from Outperform at Raymond James » 06:59
02/14/20
02/14
06:59
02/14/20
06:59
TRUP

Trupanion

$36.51 /

+0.91 (+2.56%)

Raymond James analyst…

Raymond James analyst John Ransom downgraded Trupanion to Market Perform from Outperform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Trupanion reports Q4 EPS 2c, consensus 1c » 16:19
02/13/20
02/13
16:19
02/13/20
16:19
TRUP

Trupanion

$36.51 /

+0.91 (+2.56%)

Reports Q4 revenue…

Reports Q4 revenue $105.5M, consensus $104.89M. "Over the past two decades, we've delivered consistent growth while scaling our operating expenses," said Darryl Rawlings, Founder and CEO of Trupanion. "The consistency of our growth highlights our recurring revenue, supported by industry leading retention rates, and deep competitive moats. Our moats have taken decades for us to dig and position us to benefit from the growing spotlight on our category."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Zoetis sees FY20 adj. EPS $3.90-$4.00, consensus $4.01 » 07:07
02/13/20
02/13
07:07
02/13/20
07:07
ZTS

Zoetis

$143.04 /

-0.93 (-0.65%)

Sees FY20 revenue…

Sees FY20 revenue $6.65B-$6.8B, consensus $6.7B.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.